Pulse lineResearch With Heart Logo

ARIC Publications

Filters: Keyword is Apolipoproteins E  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Blair CK, Folsom AR, Knopman DS, Bray MS, Mosley TH, Boerwinkle E. "APOE genotype and cognitive decline in a middle-aged cohort." Neurology. 2005;64(2):268-76.
Maxwell TJ, Ballantyne CM, Cheverud JM, Guild CS, Ndumele CE. "APOE modulates the correlation between triglycerides, cholesterol, and CHD through pleiotropy, and gene-by-gene interactions." Genetics. 2013;195(4):1397-405.
Klos K, Shimmin L, Ballantyne C, et al. "APOE/C1/C4/C2 hepatic control region polymorphism influences plasma apoE and LDL cholesterol levels." Hum Mol Genet. 2008;17(13):2039-46.
Hsu CC, Kao LWH, Coresh J, et al. "Apolipoprotein E and progression of chronic kidney disease." JAMA. 2005;293(23):2892-9.
Wong T Y, Shankar A, Klein R, et al. "Apolipoprotein E gene and early age-related maculopathy: the Atherosclerosis Risk in Communities Study." Ophthalmology. 2006;113(2):255-9.
Boland LL, Folsom AR, Boerwinkle E. "Apolipoprotein E genotype and gallbladder disease risk in a large population-based cohort." Ann Epidemiol. 2006;16(10):763-9.
Sturgeon JD, Folsom AR, Bray MS, Boerwinkle E, Ballantyne CM. "Apolipoprotein E genotype and incident ischemic stroke: the Atherosclerosis Risk in Communities Study." Stroke. 2005;36(11):2484-6.
Surguchov AP, Boerwinkle E, Sharett AR, Patsch WP. "Apolipoprotein E genotype and lipid transport: insight into the role of the epsilon 4 allele." Atherosclerosis. 1994;106(1):119-21.
Boerwinkle E, Brown S, Sharrett AR, Heiss G, Patsch W. "Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations." Am J Hum Genet. 1994;54(2):341-60.
Volcik KA, Barkley R A, Hutchinson RG, et al. "Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants." Am J Epidemiol. 2006;164(4):342-8.
Gottesman RF, Schneider ALC, Zhou Y, et al. "Association Between Midlife Vascular Risk Factors and Estimated Brain Amyloid Deposition." JAMA. 2017;317(14):1443-1450.
Chauhan G, Adams HHH, Bis JC, et al. "Association of Alzheimer's disease GWAS loci with MRI markers of brain aging." Neurobiol Aging. 2015;36(4):1765.e7-1765.e16.
Knol MJ, Lu D, Traylor M, et al. "Association of common genetic variants with brain microbleeds: A genome-wide association study." Neurology. 2020;95(24):e3331-e3343.
C
Kou M, Ding N, Ballew SH, et al. "Conventional and Novel Lipid Measures and Risk of Peripheral Artery Disease." Arterioscler Thromb Vasc Biol. 2021;41(3):1229-1238.
E
Surguchov AP, Boerwinkle E, Sharrett AR, Patsch W. "Effect of apolipoprotein E polymorphism on fasting retinyl palmitate level." Biochem Mol Med. 1995;55(2):156-7.
L
Chamberlain AM, Folsom AR, Schreiner PJ, Boerwinkle E, Ballantyne CM. "Low-density lipoprotein and high-density lipoprotein cholesterol levels in relation to genetic polymorphisms and menopausal status: the Atherosclerosis Risk in Communities (ARIC) Study." Atherosclerosis. 2008;200(2):322-8.
Morrison AC, Ballantyne CM, Bray M, Chambless LE, A Sharrett R, Boerwinkle E. "LPL polymorphism predicts stroke risk in men." Genet Epidemiol. 2002;22(3):233-42.
R
de Andrade M, Thandi I, Brown S, Gotto A, Patsch W, Boerwinkle E. "Relationship of the apolipoprotein E polymorphism with carotid artery atherosclerosis." Am J Hum Genet. 1995;56(6):1379-90.
Saeed A, Feofanova EV, Yu B, et al. "Remnant-Like Particle Cholesterol, Low-Density Lipoprotein Triglycerides, and Incident Cardiovascular Disease." J Am Coll Cardiol. 2018;72(2):156-169.